Abstract
Background:
The emergence and spread of carbapenem-resistant Klebsiella pneumoniae (CRKP) represent a major threat to global public health, necessitating effective therapeutic strategies to prevent infection.
Materials and Methods:
A novel bacteriophage, φKP-C01, was isolated and characterized using ST307KL102 CRKP as the host.
Results:
One-step growth curve analysis and complete genome sequencing demonstrated φKP-C01 to be a highly efficient lytic phage. The absence of genes encoding virulence factors, drug resistance determinants, or lysogeny-related functions indicated its potential safety for therapeutic applications. Bioinformatic analysis identified orf5 as encoding Depo-C01, a putative tail fiber protein with predicted depolymerase activity. To validate this function, orf5 was cloned, and recombinant Depo-C01 was expressed and purified. Depolymerase activity specifically targeting the KL102 capsular polysaccharide of the CRKP host was confirmed via spot assay and transmission electron microscopy.
Conclusion:
Lytic phage φKP-C01 and its depolymerase Depo-C01 show strong potential for phage-based or enzymatic strategies targeting CRKP infections.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
